Estrogen Receptor

Authoritative sources

• Wikidata (Q422975)
• MeSH (D011960)
• Wikipedia

Evidence base

• Randomized Controlled Trial · 2025

  Imlunestrant with or without Abemaciclib in Advanced Breast Cancer

  The New England journal of medicine · Jhaveri KL, Neven P, Casalnuovo ML, Kim SB, et al.

• Randomized Controlled Trial · 2025

  First-Line Camizestrant for Emerging ESR1-Mutated Advanced Breast Cancer

  The New England journal of medicine · Bidard FC, Mayer EL, Park YH, Janni W, et al.

• Randomized Controlled Trial · 2025

  Vepdegestrant, a PROTAC Estrogen Receptor Degrader, in Advanced Breast Cancer

  The New England journal of medicine · Campone M, De Laurentiis M, Jhaveri K, Hu X, et al.

• Randomized Controlled Trial · 2025

  Pembrolizumab and chemotherapy in high-risk, early-stage, ER(+)/HER2(-) breast cancer: a randomized phase 3 trial

  Nature medicine · Cardoso F, O'Shaughnessy J, Liu Z, McArthur H, et al.

• Randomized Controlled Trial · 2024

  Elacestrant in ER+, HER2- Metastatic Breast Cancer with ESR1-Mutated Tumors: Subgroup Analyses from the Phase III EMERALD Trial by Prior Duration of Endocrine Therapy plus CDK4/6 Inhibitor and in Clinical Subgroups

  Clinical cancer research : an official journal of the American Association for Cancer Research · Bardia A, Cortés J, Bidard FC, Neven P, et al.

• Randomized Controlled Trial · 2024

  Overall Survival With Palbociclib Plus Letrozole in Advanced Breast Cancer

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology · Slamon DJ, Diéras V, Rugo HS, Harbeck N, et al.

• Meta-Analysis · 2023

  Clomiphene citrate for male infertility: A systematic review and meta-analysis

  Andrology · Huijben M, Huijsmans RLN, Lock MTWT, de Kemp VF, et al.

• Randomized Controlled Trial · 2022

  Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Results From the Randomized Phase III EMERALD Trial

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology · Bidard FC, Kaklamani VG, Neven P, Streich G, et al.

Where Estrogen Receptor appears on Kindr Health